Den Europæiske Union - svensk - EMA (European Medicines Agency)

zoetis belgium sa - hund parainfluensa typ 2 virus, stam cpiv-2 bio 15 (levande dämpad) - immunologicals för canidae, levande virala vacciner - hundar - aktiv immunisering av hundar från sex veckors ålder för att förhindra kliniska tecken (nasal och okulär urladdning) och minska viral utsöndring orsakad av hundparainfluensavirus.

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

theramex ireland limited - risedronatnatrium - enterotablett - 35 mg - risedronatnatrium 35 mg aktiv substans

Den Europæiske Union - svensk - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cystisk fibros - andra andningsorganprodukter - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

ceva-phylaxia veterinary biologicals co. ltd. - infektiöst fågelbronkitvirus, stam massachusetts b48, levande försvagat - frystorkat pulver till okulonasal suspension - laktosmonohydrat hjälpämne; sackaros hjälpämne; sorbitol hjälpämne; infektiöst fågelbronkitvirus, stam massachusetts b48, levande försvagat 2,8 - 4,3 log10 eid50 aktiv substans - fjäderfä

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

zoetis animal health aps - hundadenovirus typ 2 (cav-2), stam cav-2-bio 13, levande försvagat; hundparvovirus typ 2b, stam cpv-2b-bio 12/b, levande försvagat ; valpsjukevirus (cdv), stam bio 11/a, levande försvagat - frystorkat pulver och vätska till injektionsvätska, suspension - hundadenovirus typ 2 (cav-2), stam cav-2-bio 13, levande försvagat 3,6 - 5,3 log10 tcid50 aktiv substans; valpsjukevirus (cdv), stam bio 11/a, levande försvagat 3,1 - 5,1 log10 tcid50 aktiv substans; sackaros hjälpämne; hundparvovirus typ 2b, stam cpv-2b-bio 12/b, levande försvagat 4,3 - 6,6 log10 tcid50 aktiv substans - hund

Den Europæiske Union - svensk - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - grisar - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Den Europæiske Union - svensk - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - grisar - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Den Europæiske Union - svensk - EMA (European Medicines Agency)

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

boehringer ingelheim vetmedica gmbh - escherichia coli, strain o8:k35, f5 (k99) fimbrieadhesin, inaktiverad; bovint coronavirus (bcv), stam c-197, inaktiverat ; bovint rotavirus, stam tm-91, inaktiverat - injektionsvätska, suspension - formaldehyd hjälpämne; tiomersal hjälpämne; quil a 0,4 mg adjuvans; aluminiumoxid, hydratiserad 6 mg adjuvans; bovint coronavirus (bcv), stam c-197, inaktiverat 1 rp aktiv substans; bovint rotavirus, stam tm-91, inaktiverat 1 rp aktiv substans; escherichia coli, strain o8:k35, f5 (k99) fimbrieadhesin, inaktiverad 1 rp aktiv substans - nöt

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

doc generici srl - deferipron - filmdragerad tablett - 500 mg - deferipron 500 mg aktiv substans